Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02620241
Other study ID # VrijeUB
Secondary ID
Status Completed
Phase N/A
First received November 30, 2015
Last updated November 6, 2017
Start date October 2015
Est. completion date October 2017

Study information

Verified date November 2017
Source Vrije Universiteit Brussel
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The study evaluates the effect on gastro-oesophageal reflux (GOR) of infants sitting in a stable upright position during 20 min. This is an addendum to the previous study with record number clinical trials.gov NCT02124863


Recruitment information / eligibility

Status Completed
Enrollment 50
Est. completion date October 2017
Est. primary completion date October 2017
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group N/A to 365 Days
Eligibility Inclusion Criteria:

- Each child under the age of one year that was referred for 24h pH-MII monitoring to exclude pathological gastro-oesophageal reflux (GOR)

Exclusion Criteria:

- : prematurity (gestational age less than 37 weeks), the use of anti-reflux medication and reflux surgery (Nissen fundoplication)

Study Design


Related Conditions & MeSH terms


Intervention

Other:
sitting position


Locations

Country Name City State
Belgium UZBrussel Jette Brussels

Sponsors (1)

Lead Sponsor Collaborator
Vrije Universiteit Brussel

Country where clinical trial is conducted

Belgium, 

Outcome

Type Measure Description Time frame Safety issue
Primary number of reflux episodes number of reflux episodes is counted over 20 min period of time 20 minutes
See also
  Status Clinical Trial Phase
Completed NCT02124863 - Influence of IPV on GOR in Infants From 0 to 12 Months. N/A
Withdrawn NCT02290626 - Elemental Diets vs. Semi-solid Diets on Gastric Excretion and Gastroesophageal Regurgitation N/A
Completed NCT00464308 - A Study to Compare the Number of Patients With Gastro-Oesophageal Reflux Disease (GORD) Achieving Heartburn and Regurgitation Symptom Resolution After Treatment With Either Rabeprazole Sodium 20mg, Esomeprazole 20mg or Esomeprazole 40mg Phase 4
Completed NCT02457429 - A Validation Study of the Dx-pH Probe in Children for the Detection of Extra-oesophageal Reflux N/A
Completed NCT01601379 - Observational Study (This Means That no Drug is Tested) in Patients Suffering of Gastroesophageal Reflux Disease. Phase 4
Completed NCT03346174 - Influence of Airway Clearance Techniques on GOR in Infants N/A
Completed NCT00231543 - Laparoscopy in Children: Does it Decrease the Metabolic, Endocrine and Inflammatory Stress Response to Surgery N/A